BioSyntech Inc. discovers, develops, and manufactures regenerative medicine products and therapeutic delivery systems. The Company's primary activity is tissue repair through its platform technology, BST-Gel. BioSyntech is seeking to license its products for regenerative medicine, orthopedics, reconstructive surgery, oncology, vaccines, and therapeutics to marketing partners worldwide.
475, Armand-Frappier Boulevard
Laval, QC H7V 4B3